Caption Management, LLC Kodiak Sciences Inc. Call Options Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.48 $151,200 - $284,400	-30,000 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$7.09 - $89.45 $212,700 - $2.68 Million	30,000 New	30,000 $232,000
Q1 2021 May 17, 2021	SELL	$110.45 - $164.47 $2.21 Million - $3.29 Million	-20,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$60.78 - $154.03 $1.22 Million - $3.08 Million	20,000 New	20,000 $2.94 Million
Q2 2020 Aug 14, 2020	SELL	$42.74 - $66.25 $1.07 Million - $1.66 Million	-25,000 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$38.18 - $73.95 $2.48 Million - $4.81 Million	-65,000 Reduced 72.22%	25,000 $1.19 Million
Q4 2019 Feb 13, 2020	BUY	$13.9 - $76.65 $1.25 Million - $6.9 Million	90,000 New	90,000 $6.48 Million

104

39.8M

7.6K

3.5K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $138M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.